As compared to other benzodiazepines, Etilaam has lesser sedative effects, lower dependence, and lower tolerance. However, long-term use can reduce the effectivity of the medicine and may cause dependence and addiction.

This medication is a hypnotic and sedative, prescribed for anxiety, and sleep disorders.

Alzolam 0.5mg Tablet belong to a class of medicines called benzodiazepines and hydrocodone belongs to the class of medicines called opioids. Both the classes cause sedation (increased tendency to sleep) and respiratory depression (slow and difficult breathing).

Commonly reported side effects of escitalopram include: diarrhea, drowsiness, ejaculatory disorder, headache, insomnia, nausea, and delayed ejaculation. Other side effects include: anorgasmia, constipation, dizziness, dyspepsia, fatigue, decreased libido, diaphoresis, and xerostomia.

Yes, like benzodiazepines, it causes muscle relaxation, but otherwise it is mainly used for anxiety.

No, Etilaam is not an antidepressant. It is used for the treatment of generalized anxiety disorder with depressive symptoms. But, it may affect patients mood.

Etizolam is currently legal with a prescription in Japan, Italy and India.

The duration is generally 6-8 hours although higher doses can last longer. Usual after effects are between 1-5 hours although many users report little after effects, especially if they have had a 7-8 hour period of uninterrupted sleep after use.

Etizolam depresses the central nervous system and animal testing seems to point toward its effectiveness as a muscle relaxer, anti-convulsion medication, sleep aid, sedative and anti-anxiety medication.

Stopping Etilaam suddenly may cause withdrawal symptoms which may include anxiety, insomnia, headache, dizziness, ringing sound in ear (tinnitus), eating disorder (anorexia), vomiting, nausea, tremor, weakness, excessive sweating (perspiration), irritability, hypersensitivity to visual and auditory stimuli. Stopping the medicine suddenly may also cause palpitations, fast heart rate and postural hypotension (drop in blood pressure on standing). In severe and rare cases of withdrawal from high doses, patients may develop seizures, mental disorder (psychosis), agitation, confusion, and hallucinations.

Etizolam also possessed a more marked antidepressant effect than did alprazolam or bromazepam.

Yes, there are several reports mentioning the abuse potential of Etilaam. Therefore, it should be used with caution in patients prone to drug abuse.

Etizolam has been usually presented as a valid and apparently safer alternative to benzodiazepines as treatment for several psychiatric syndromes, such as anxiety and insomnia. As reported in the literature, side effects occurring at therapeutic doses of 1–1.5 mg/day are negligible [[1], [2], [3], [4], [5], [6], [7]].

Major adverse effects include drowsiness, sedation, muscle weakness and incoordination, fainting, headache, confusion, depression, slurred speech, visual disturbances and changes in libido and tremor ⁸.

Etilaam 0.5 Tablet is a prescription medicine used to treat short term anxiety and insomnia. It binds to specific receptor sites in the brain and calms the brain. Therefore, it provides effective relaxation to the brain.

Oral doses of Etilaam begin working within 30-60 minutes and peak at 3-4 hours. The medicine remains in the body for 6-8 hours although higher doses can last longer.

Like other benzodiazepines, it causes sleepiness but is mainly used for anxiety disorder. It increases total sleep time and decreases the proportion of rapid eye movement (REM) sleep, wherein your eyes move quickly in different directions. Etilaam had no effect on sleep latency (amount of time it takes you to go from being fully awake to being asleep).

It is required that activities requiring mental alertness not be performed while taking this drug. Furthermore, this drug caused changes in the blood pressure by either lowering it or increasing it. Henceforth it is required that people having high blood pressure should use this drug with caution.

The Food and Drug Administration (FDA) has not approved Etizolam for use as a drug, and thus it cannot be sold or prescribed in the United States.